Markus R Meyer

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 44

Top Topics

Liquid Chromatography

Mass Spectrometry

Solid Phase Extraction

Top Venues

Drug testing and analysis

Arteriosclerosis, thrombosis, and vascular biology

Journal of neurochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Damian Martus, Sarah K Williams, Kira Pichi, Stefanie Mannebach-Götz, Nicolas Kaiser, Barbara Wardas, Claudia Fecher-Trost, Markus R Meyer, Frank Schmitz, Andreas Beck, Richard Fairless, Ricarda Diem, Veit Flockerzi, Anouar Belkacemi
Cavβ3 Contributes to the Maintenance of the Blood-Brain Barrier and Alleviates Symptoms of Experimental Autoimmune Encephalitis. Arteriosclerosis, thrombosis, and vascular biology (2024)
Sascha K Manier, Paula Mumber, Josef Zapp, Niels Eckstein, Markus R Meyer
Characterization and Metabolism of Drug Products Containing the Cocaine-Like New Psychoactive Substances Indatraline and Troparil. Metabolites 14 (6) (2024)
Ana Sofia Alberto-Silva, Selina Hemmer, Hailey A Bock, Leticia Alves da Silva, Kenneth R Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek, Elena Bossi, Thomas Stockner, Markus R Meyer, John D McCorvy, Simon D Brandt, Pierce V Kavanagh, Harald H Sitte
Bioisosteric analogs of MDMA: Improving the pharmacological profile? Journal of neurochemistry (2024)
Damian Martus, Sarah K Williams, Kira Pichi, Stefanie Mannebach-Götz, Nicolas Kaiser, Barbara Wardas, Claudia Fecher-Trost, Markus R Meyer, Frank Schmitz, Andreas Beck, Richard Fairless, Ricarda Diem, Veit Flockerzi, Anouar Belkacemi
Cavβ3 Contributes to the Maintenance of the Blood-Brain Barrier and Alleviates Symptoms of Experimental Autoimmune Encephalomyelitis. Arteriosclerosis, thrombosis, and vascular biology 44 (8) (2024)
Ana Sofia Alberto-Silva, Selina Hemmer, Hailey A Bock, Leticia Alves da Silva, Kenneth R Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek, Elena Bossi, Thomas Stockner, Markus R Meyer, John D McCorvy, Simon D Brandt, Pierce V Kavanagh, Harald H Sitte
Bioisosteric analogs of MDMA with improved pharmacological profile. bioRxiv : the preprint server for biology (2024)
Sascha K Manier, Paula Mumber, Josef Zapp, Niels Eckstein, Markus R Meyer
Characterization and Metabolism of Drug Products Containing the Cocaine-Like New Psychoactive Substances Indatraline and Troparil. Metabolites 14 (6) (2024)
Fabian Frankenfeld, Lea Wagmann, Anush Abelian, Jason Wallach, Adeboye Adejare, Simon D Brandt, Markus R Meyer
In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry. Metabolites 14 (5) (2024)
Ana Sofia Alberto-Silva, Selina Hemmer, Hailey A Bock, Leticia Alves da Silva, Kenneth R Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek, Elena Bossi, Thomas Stockner, Markus R Meyer, John D McCorvy, Simon D Brandt, Pierce V Kavanagh, Harald H Sitte
Bioisosteric analogs of MDMA: Improving the pharmacological profile? Journal of neurochemistry (2024)
Damian Martus, Sarah K Williams, Kira Pichi, Stefanie Mannebach-Götz, Nicolas Kaiser, Barbara Wardas, Claudia Fecher-Trost, Markus R Meyer, Frank Schmitz, Andreas Beck, Richard Fairless, Ricarda Diem, Veit Flockerzi, Anouar Belkacemi
Cavβ3 Contributes to the Maintenance of the Blood-Brain Barrier and Alleviates Symptoms of Experimental Autoimmune Encephalomyelitis. Arteriosclerosis, thrombosis, and vascular biology 44 (8) (2024)
Ana Sofia Alberto-Silva, Selina Hemmer, Hailey A Bock, Leticia Alves da Silva, Kenneth R Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek, Elena Bossi, Thomas Stockner, Markus R Meyer, John D McCorvy, Simon D Brandt, Pierce V Kavanagh, Harald H Sitte
Bioisosteric analogs of MDMA with improved pharmacological profile. bioRxiv : the preprint server for biology (2024)
Ana Sofia Alberto-Silva, Selina Hemmer, Hailey A Bock, Leticia Alves da Silva, Kenneth R Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek, Elena Bossi, Thomas Stockner, Markus R Meyer, John D McCorvy, Simon D Brandt, Pierce V Kavanagh, Harald H Sitte
Bioisosteric analogs of MDMA with improved pharmacological profile. bioRxiv : the preprint server for biology (2024)
Fabian Frankenfeld, Lea Wagmann, Cathy M Jacobs, Markus R Meyer
Prevalence of Drugs of Abuse and Cognitive Enhancer Consumption Monitored in Grab Samples and Composite Wastewater via Orbitrap Mass Spectrometry Analysis. Molecules (Basel, Switzerland) 29 (16) (2024)
Damian Martus, Sarah K Williams, Kira Pichi, Stefanie Mannebach-Götz, Nicolas Kaiser, Barbara Wardas, Claudia Fecher-Trost, Markus R Meyer, Frank Schmitz, Andreas Beck, Richard Fairless, Ricarda Diem, Veit Flockerzi, Anouar Belkacemi
Cavβ3 Contributes to the Maintenance of the Blood-Brain Barrier and Alleviates Symptoms of Experimental Autoimmune Encephalomyelitis. Arteriosclerosis, thrombosis, and vascular biology 44 (8) (2024)
Fabian Frankenfeld, Lea Wagmann, Anush Abelian, Jason Wallach, Adeboye Adejare, Simon D Brandt, Markus R Meyer
In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry. Metabolites 14 (5) (2024)
Fabian Frankenfeld, Lea Wagmann, Anush Abelian, Jason Wallach, Adeboye Adejare, Simon D Brandt, Markus R Meyer
In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry. Metabolites 14 (5) (2024)
Ana Sofia Alberto-Silva, Selina Hemmer, Hailey A Bock, Leticia Alves da Silva, Kenneth R Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek, Elena Bossi, Thomas Stockner, Markus R Meyer, John D McCorvy, Simon D Brandt, Pierce V Kavanagh, Harald H Sitte
Bioisosteric analogs of MDMA: Improving the pharmacological profile? Journal of neurochemistry (2024)
Sascha K Manier, Paula Mumber, Josef Zapp, Niels Eckstein, Markus R Meyer
Characterization and Metabolism of Drug Products Containing the Cocaine-Like New Psychoactive Substances Indatraline and Troparil. Metabolites 14 (6) (2024)
Yu Mi Park, Markus R Meyer, Daniel Krug, Jennifer Herrmann
Optimization of Mass Spectrometry Imaging for Drug Metabolism and Distribution Studies in the Zebrafish Larvae Model: A Case Study with the Opioid Antagonist Naloxone. International journal of molecular sciences 24 (12) (2023)
Yu Mi Park, Markus R Meyer, Daniel Krug, Jennifer Herrmann
Optimization of Mass Spectrometry Imaging for Drug Metabolism and Distribution Studies in the Zebrafish Larvae Model: A Case Study with the Opioid Antagonist Naloxone. International journal of molecular sciences 24 (12) (2023)
Fabian Frankenfeld, Lea Wagmann, Cathy M Jacobs, Markus R Meyer
Quantitative analysis of drugs of abuse and cognitive enhancers in influent wastewater by means of two chromatographic methods. Drug testing and analysis (2023)
Yu Mi Park, Markus R Meyer, Daniel Krug, Jennifer Herrmann
Optimization of Mass Spectrometry Imaging for Drug Metabolism and Distribution Studies in the Zebrafish Larvae Model: A Case Study with the Opioid Antagonist Naloxone. International journal of molecular sciences 24 (12) (2023)
Frederike Nordmeier, Adrian A Doerr, Stefan Potente, Nadja Walle, Matthias W Laschke, Michael D Menger, Peter H Schmidt, Markus R Meyer, Nadine Schaefer
Are the (New) Synthetic Opioids U-47700, Tramadol and Their Main Metabolites Prone to Time-dependent Postmortem redistribution?-A Systematic Study Using an in Vivo Pig Model. Journal of analytical toxicology (2022)
Cathy M Jacobs, Lea Wagmann, Markus R Meyer
Analytical toxicology of yew constituents in human blood and urine by liquid chromatography-high-resolution tandem mass spectrometry. Drug testing and analysis (2022)
Matthias J Richter, Lea Wagmann, Simon D Brandt, Markus R Meyer
In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists 2F-QMPSB and SGT-233 Including Isozyme Mapping and Carboxylesterases Activity Testing. Journal of analytical toxicology (2022)
Matthias J Richter, Lea Wagmann, Pierce V Kavanagh, Simon D Brandt, Markus R Meyer
In vitro metabolic fate of the synthetic cannabinoid receptor agonists (quinolin-8-yl 4-methyl-3-(morpholine-4-sulfonyl)benzoate [QMMSB]) and (quinolin-8-yl 4-methyl-3-((propan-2-yl)sulfamoyl)benzoate [QMiPSB]) including isozyme mapping and carboxylesterases activity testing. Drug testing and analysis (2022)
Cathy M Jacobs, Lea Wagmann, Fabian Frankenfeld, Markus R Meyer
Clinical Toxicological Follow-Up Analysis of a Suicide Attempt Using Chloroquine. Journal of analytical toxicology (2022)
Sascha K Manier, Lea Wagmann, Armin A Weber, Markus R Meyer
Abuse of nutmeg seeds: Detectable by means of liquid chromatography-mass spectrometry techniques? Drug testing and analysis 13 (7) (2021)
Thomas P Bambauer, Lea Wagmann, Armin A Weber, Markus R Meyer
Further development of a liquid chromatography-high-resolution mass spectrometry/mass spectrometry-based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or Ricinus communis ingestions. Drug testing and analysis 13 (9) (2021)
Aline C Vollmer, Lea Wagmann, Markus R Meyer
Toxic plants-Detection of colchicine in a fast systematic clinical toxicology screening using liquid chromatography-mass spectrometry. Drug testing and analysis (2021)
Tanja M Gampfer, Lea Wagmann, Anouar Belkacemi, Veit Flockerzi, Markus R Meyer
Cytotoxicity, metabolism, and isozyme mapping of the synthetic cannabinoids JWH-200, A-796260, and 5F-EMB-PINACA studied by means of in vitro systems. Archives of toxicology 95 (11) (2021)
Selina Hemmer, Lea Wagmann, Markus R Meyer
Altered metabolic pathways elucidated via untargeted in vivo toxicometabolomics in rat urine and plasma samples collected after controlled application of a human equivalent amphetamine dose. Archives of toxicology 95 (10) (2021)
Sascha K Manier, Markus R Meyer
Impact of the used solvent on the reconstitution efficiency of evaporated biosamples for untargeted metabolomics studies. Metabolomics : Official journal of the Metabolomic Society 16 (3) (2020)
Lea Wagmann, Nora Hempel, Lilian H J Richter, Simon D Brandt, Alexander Stratford, Markus R Meyer
Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings. Drug testing and analysis 11 (10) (2019)
Tanja M Gampfer, Lilian H J Richter, Jan Schäper, Lea Wagmann, Markus R Meyer
Toxicokinetics and analytical toxicology of the abused opioid U-48800 - in vitro metabolism, metabolic stability, isozyme mapping, and plasma protein binding. Drug testing and analysis 11 (10) (2019)
Sascha K Manier, Christina Felske, Niels Eckstein, Markus R Meyer
The metabolic fate of two new psychoactive substances - 2-aminoindane and N-methyl-2-aminoindane - studied in vitro and in vivo to support drug testing. Drug testing and analysis 12 (1) (2019)
Lea Wagmann, Simon D Brandt, Alexander Stratford, Hans H Maurer, Markus R Meyer
Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases. Drug testing and analysis 11 (2) (2018)
Sascha K Manier, Lilian H J Richter, Jan Schäper, Hans H Maurer, Markus R Meyer
Different in vitro and in vivo tools for elucidating the human metabolism of alpha-cathinone-derived drugs of abuse. Drug testing and analysis (2018)
Lilian H J Richter, Hans H Maurer, Markus R Meyer
Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry. Drug testing and analysis 11 (2) (2018)
Madeleine Pettersson Bergstrand, Lilian H J Richter, Hans H Maurer, Lea Wagmann, Markus R Meyer
In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases. Drug testing and analysis 11 (1) (2018)
Sascha K Manier, Andreas Keller, Markus R Meyer
Automated optimization of XCMS parameters for improved peak picking of liquid chromatography-mass spectrometry data using the coefficient of variation and parameter sweeping for untargeted metabolomics. Drug testing and analysis 11 (6) (2018)
Achim T Caspar, Jonas B Gaab, Julian A Michely, Simon D Brandt, Markus R Meyer, Hans H Maurer
Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MSn , and LC-HR-MS/MS. Drug testing and analysis 10 (1) (2017)
Madeleine Pettersson Bergstrand, Markus R Meyer, Olof Beck, Anders Helander
Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry. Drug testing and analysis 10 (3) (2017)
Julian A Michely, Markus R Meyer, Hans H Maurer
Power of Orbitrap-based LC-high resolution-MS/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MSn or GC-MS procedures. Drug testing and analysis 10 (1) (2017)
Marie Mardal, Markus Bischoff, María Ibáñez, Ulla Ruffing, Félix Hernández, Markus R Meyer
Microbial biotransformation of five pyrrolidinophenone-type psychoactive substances in wastewater and a wastewater isolated Pseudomonas putida strain. Drug testing and analysis 9 (10) (2017)